In this episode, CEO Michael Maslansky, and Partners Lee Carter and Katie Cronen delve into the pharmaceutical industry's enduring reputation struggles, tracing their origins back to pre-pandemic times and exploring the transformative impact of COVID-19. Through insightful discussions and case studies, they'll propose strategies for reshaping the industry's narrative, emphasizing the importance of recasting pharma as more than profit-driven entities and fostering consumer trust.
